In this study, it was found that TPM1, TPM3, and TPM4 were significantly upregulated in gliomas, while a high expression level of TPM2, TPM3, and TPM4 was significantly correlated with poorer prognosis. The gene discussed is TPM1; the disease is central nervous system cancer.